Century Therapeutics Inc Dividends

The next dividend date for Century Therapeutics Inc has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Century Therapeutics Inc (IPSC)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Century Therapeutics Inc

Country
USA
Full Time Employees
140

Century Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed and refractory B-cell lymphoma. The company is also involved in the development of CNTY-308, a CD19-targeted CAR-iT cell therapy engineered with Allo-Evasion 5.0 demonstrating preclinical efficacy comparable to autologous CD19 CAR-T cells for the treatment of B-cell mediated autoimmune diseases and malignancies; and CNTY-341, A CD19/CD22 dual-targeted CAR-iT cell therapy engineered with Allo-Evasion 5.0 which pairs dual targeting and primary T-cell-like functionality in an allogeneic cell with the goal of providing a differentiated therapy for B cell malignancies that are in preclinical trial. In addition, it develops solid tumor CAR iT program exploiting Nectin-4 CAR and other validated targets, engineered with Allo-Evasion 5.0 and additional engineering aimed at overcoming the key barriers to success in solid tumors, as well as non-immune effector. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Owning Century Therapeutics Inc Stock on the Dividend Date

If you own Century Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Century Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Century Therapeutics Inc stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Century Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Century Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Century Therapeutics Inc Dividends

You can contact us any time if you would like to ask questions about Century Therapeutics Inc dividends or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.